ArticleFrontiers in oncology2026

Icaritin inhibits breast cancer through activating MT1X to promote ferroptosis and synergizing with NF-κB pathway suppression.

Fenglin Zhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.